Seelos Therapeutics (SEEL)

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q4 2017 Results - Earnings Call Transcript
March 1, 2018 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Richard Pascoe on Q3 2017 Results - Earnings Call Transcript
Nov. 5, 2017 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences's (APRI) CEO Richard Pascoe on Q2 2017 Results - Earnings Call Transcript
Aug. 2, 2017 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Richard Pascoe on Q1 2017 Results - Earnings Call Transcript
May 11, 2017 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Richard Pascoe on Q4 2016 Results - Earnings Call Transcript
March 13, 2017 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q3 2016 Results - Earnings Call Transcript
Nov. 8, 2016 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Richard Pascoe on Q2 2016 Results - Earnings Call Transcript
Aug. 7, 2016 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q1 2016 Results - Earnings Call Transcript
May 9, 2016 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences (APRI) Q4 2015 Results - Earnings Call Webcast
March 9, 2016 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q4 2015 Results - Earnings Call Transcript
March 9, 2016 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q3 2015 Results - Earnings Call Transcript
Nov. 9, 2015 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences (APRI) Q3 2015 Results - Earnings Call Webcast
Nov. 5, 2015 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences (APRI) Q2 2015 Results - Earnings Call Webcast
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

Apricus' (APRI) CEO Rich Pascoe on Q2 2015 Results - Earnings Call Transcript
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences (APRI) Q1 2015 Results - Earnings Call Webcast
May 11, 2015 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q1 2015 Results - Earnings Call Transcript
May 11, 2015 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q4 2014 Results - Earnings Call Transcript
March 16, 2015 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences (APRI) Q4 2014 Results - Earnings Call Webcast
March 16, 2015 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q3 2014 Results -- Earnings Call Transcript
Nov. 10, 2014 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' (APRI) CEO Richard Pascoe on Q2 2014 Results - Earnings Call Transcript
Aug. 12, 2014 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences (APRI) CEO Rich Pascoe on Q1 2014 Results - Earnings Call Transcript
May 12, 2014 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 17, 2014 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences Management Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences Management Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 12, 2013 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences Inc - Business Update Call Transcript
Aug. 12, 2013 | Price: Free! | Source: Earnings Impact

Apricus Biosciences, Inc. - Special Call
June 10, 2013 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences Management Discusses Q1 2013 Results - Earnings Call Transcript
May 10, 2013 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences Management Discusses 2012 Results - Earnings Call Transcript
March 18, 2013 | Price: Free! | Source: Seeking Alpha

NexMed Q3 2012 Earnings Conference Call Transcript
Nov. 9, 2012 | Price: $106.00 | Source: Thomson

Apricus Biosciences Management Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 9, 2012 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 11, 2012 | Price: Free! | Source: Seeking Alpha

Apricus Biosciences Inc Q2 2012 Earnings Conference Call Transcript
Aug. 10, 2012 | Price: $54.00 | Source: Thomson

Apricus Biosciences to Own Revenue Generating Leading French Drug Sales & Marketing Company Confere
June 20, 2012 | Price: $54.00 | Source: Thomson

Apricus Biosciences Inc at Jefferies Global Healthcare Conference Transcript
June 7, 2012 | Price: $54.00 | Source: Thomson

Apricus Biosciences Inc Q1 2012 Earnings Conference Call Transcript
May 10, 2012 | Price: $54.00 | Source: Thomson

Recent filings

Securities to be offered to employees in employee benefit plans - Aug. 15, 2019

Departure of Directors or Certain - Aug. 14, 2019

Seelos Therapeutics Just Filed Its Quarterly Report: Net Loss Per Share B... - Aug. 1, 2019

Seelos Therapeutics Announces Investigational New Drug Application Submission For Sls-005 - July 17, 2019

Seelos Therapeutics Announces Acquisition Of An Exclusive Worldwide License Of Gene Therapy Program To Address Parkinson'S Disease From Duke University - June 27, 2019

Entry into a Material Definitive - June 18, 2019

Seelos Therapeutics just filed a prospectus, suggesting it plans to soon issue some securities - June 18, 2019

Seelos Therapeutics Reports Q1 2019 Pipeline Update - May 21, 2019

Seelos Therapeutics Just Filed Its Quarterly Report: Net Loss Per Share B... - May 21, 2019

Notification of inability to timely file Form 10-Q or 10-QSB - May 15, 2019

Departure of Directors or Certain - May 13, 2019

Ligand Pharmaceuticals Incorporated just provided an update on share ownership of Seelos Therapeutics - April 15, 2019

Seelos Therapeutics releases salary data. CEO sees compensation rise 21% - April 12, 2019

Changes in - April 8, 2019

Seelos Therapeutics Just Filed Its Annual Report: 12. SUBSEQUENT EVENT... - March 28, 2019

Departure of Directors or Certain - March 26, 2019

Seelos Therapeutics director was just granted 16,000 options - March 21, 2019

Seelos Therapeutics director was just granted 40,000 options - March 21, 2019

Seelos Therapeutics director was just granted 40,000 options - March 21, 2019

Seelos Therapeutics director was just granted 40,000 options - March 21, 2019

Heights Capital Management, Inc. just provided an update on share ownership of Seelos Therapeutics - March 11, 2019

Apricus Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - March 8, 2019

Entry into a Material Definitive - March 8, 2019

Departure of Directors or Certain - March 1, 2019

Securities to be offered to employees in employee benefit plans - Feb. 25, 2019

Apricus: Seelos Therapeutics Completes Acquisition Of Trehalose From Bioblast Pharma - Feb. 19, 2019

Steven Boyd just provided an update on activist position in Apricus Biosciences - Feb. 14, 2019

Statement of acquisition of beneficial ownership by individuals - Feb. 14, 2019

Apricus Biosciences Just Received a Notice of Effectiveness - Feb. 13, 2019

Apricus Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 13, 2019

Apricus Biosciences Just Received a Notice of Effectiveness - Feb. 13, 2019

Apricus Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 13, 2019

Statement of acquisition of beneficial ownership by individuals - Feb. 8, 2019

Entry into a Material Definitive - Feb. 6, 2019

Registration statement under Securities Act of 1933 - Feb. 1, 2019

Registration statement under Securities Act of 1933 - Feb. 1, 2019

Raj Mehra, Ph.D. just provided an update on activist position in Apricus Biosciences - Jan. 31, 2019

Financial Statements and - Jan. 30, 2019

Apricus Biosciences director just declared ownership of no shares of Apricus Biosciences - Jan. 28, 2019

Apricus Biosciences director just declared ownership of no shares of Apricus Biosciences - Jan. 28, 2019

Apricus Biosciences's See Remarks just declared ownership of no shares of Apricus Biosciences - Jan. 28, 2019

Major owner of Apricus Biosciences just picked up 3,081,546 shares - Jan. 28, 2019

Apricus Biosciences director just declared ownership of no shares of Apricus Biosciences - Jan. 28, 2019

Apricus Biosciences's CEO & Secretary just disposed of 44,810 shares - Jan. 24, 2019

Current report, item 8.01 - Jan. 24, 2019

SVP of Apricus Biosciences just disposed of 32,705 shares - Jan. 24, 2019

Seelos Therapeutics, Inc. Announces Successful Completion Of Its Merger With Apricus Biosciences, Inc. To Advance Late-Stage Pipeline Of Products For Central Nervous System (Cns) Disorders - Jan. 24, 2019

Apricus: Unaudited Pro Forma Condensed Combined Financial Information - Jan. 16, 2019

Prospectuses and communications, business combinations - Jan. 16, 2019

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of Apricus Biosciences - Jan. 4, 2019

Prospectuses and communications, business combinations - Jan. 4, 2019

Apricus: Unaudited Pro Forma Condensed Combined Financial Information - Jan. 4, 2019

Prospectuses and communications, business combinations - Dec. 26, 2018

Prospectuses and communications, business combinations - Dec. 17, 2018

Prospectuses and communications, business combinations - Dec. 17, 2018

Prospectuses and communications, business combinations - Dec. 17, 2018

Prospectuses and communications, business combinations - Dec. 17, 2018

Prospectuses and communications, business combinations - Dec. 14, 2018

Entry into a Material Definitive Agreement - Dec. 14, 2018

Prospectuses and communications, business combinations - Dec. 6, 2018

SVP of Apricus Biosciences just disposed of 12,968 shares - Nov. 30, 2018

Prospectuses and communications, business combinations - Nov. 30, 2018

Apricus Biosciences's CEO & Secretary just disposed of 17,290 shares - Nov. 30, 2018

Apricus Biosciences Just Received a Notice of Effectiveness - Nov. 20, 2018

Entry into a Material Definitive - Nov. 16, 2018

Prospectuses and communications, business combinations - Nov. 16, 2018

Registration of securities, business combinations - Nov. 16, 2018

Registration of securities, business combinations - Oct. 24, 2018

Prospectuses and communications, business combinations - Oct. 17, 2018

Entry into a Material Definitive - Oct. 17, 2018

Notice of Delisting or Failure to Satisfy a Continued Listing Ruleor - Oct. 10, 2018

Major owner of Apricus Biosciences just declared owning 13,800,000 shares of Apricus Biosciences - Sept. 27, 2018

Steven Boyd just provided an update on activist position in Apricus Biosciences - Sept. 27, 2018

Entry into a Material Definitive - Sept. 21, 2018

Sarissa Capital Offshore Master Fund LP just provided an update on activist position in Apricus Biosciences - Sept. 5, 2018

Apricus Biosciences insider just picked up 38,550 shares - Sept. 4, 2018

Registration of securities, business combinations - Aug. 31, 2018

Departure of Directors or Certain - Aug. 31, 2018

Apricus Biosciences Provides Corporate Update And Second Quarter 2018 Financial Results - Aug. 9, 2018

Prospectuses and communications, business combinations - July 30, 2018

Apricus Biosciences, Inc. Announces Merger Agreement With Seelos Therapeutics, Inc. To Advance Late-Stage Pipeline Of Products For Central Nervous System (Cns) Disorders - July 30, 2018

Prospectuses and communications, business combinations - July 30, 2018

Apricus Biosciences Provides Corporate Update And First Quarter 2018 Financial Results - May 3, 2018

Apricus Biosciences Just Filed Its Quarterly Report: Income (Loss) Per Co... - May 3, 2018

Notice of Delisting or Failure to Satisfy a Continued Listing Ruleor - April 16, 2018

Statement of acquisition of beneficial ownership by individuals - April 9, 2018

Apricus Biosciences releases salary data. CEO sees compensation fall -21% - April 6, 2018

Apricus Biosciences Just Received a Notice of Effectiveness - April 6, 2018

Sabby Volatility Warrant Master Fund, Ltd. just provided an update on share ownership of Apricus Biosciences - March 29, 2018

Apricus Biosciences Announces Proposed Public Offering SAN DIEGO, CA, - March 29, 2018

Apricus Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - March 28, 2018

Apricus Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - March 28, 2018

Apricus Biosciences just filed a prospectus, suggesting it plans to soon issue some securities - March 27, 2018

Other preliminary proxy statements - March 26, 2018

General statement of acquisition of beneficial ownership - March 23, 2018

Major owner of Apricus Biosciences was just granted 653,409 ownership of the company. - March 23, 2018

Entry into a Material Definitive - March 23, 2018

Registration statement under Securities Act of 1933 - March 23, 2018

Apricus Biosciences Provides Corporate Update, - March 1, 2018

Apricus Biosciences Just Filed Its Annual Report: Income (Loss) Per Co... - March 1, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Sarissa Capital Domestic Fund LP 21,203,577 N/A March 3, 2016
2. RENAISSANCE TECHNOLOGIES LLC 929,465 N/A June 30, 2019
3. VANGUARD GROUP INC 239,222 N/A June 30, 2019
4. PIPER JAFFRAY & CO. 164,778 0.5 June 30, 2019
5. GEODE CAPITAL MANAGEMENT, LLC 153,707 N/A June 30, 2019
6. BlackRock Inc. 87,977 N/A Dec. 31, 2017
7. BlackRock Inc. 87,036 N/A Dec. 31, 2018
8. BlackRock Inc. 87,036 N/A Sept. 30, 2018
9. A.R.T. Advisors, LLC 52,342 N/A June 30, 2019
10. JANE STREET GROUP, LLC 50,100 N/A March 31, 2019
11. ARDSLEY ADVISORY PARTNERS 50,000 N/A June 30, 2019
12. WEDBUSH MORGAN SECURITIES INC 16,000 N/A June 30, 2019
13. NORTHERN TRUST CORP 15,300 N/A June 30, 2018
14. NORTHERN TRUST CORP 15,300 N/A June 30, 2018
15. NORTHERN TRUST CORP 15,300 N/A June 30, 2018
16. NORTHERN TRUST CORP 15,300 N/A March 31, 2018
17. NORTHERN TRUST CORP 15,300 N/A June 30, 2018
18. Citadel Advisors LLC 13,167 N/A June 30, 2019
19. BlackRock Advisors LLC 12,376 N/A Sept. 30, 2016
20. BlackRock Fund Advisors 11,422 N/A Sept. 30, 2016
21. BlackRock Inc. 8,641 N/A March 31, 2017
22. BlackRock Inc. 7,190 N/A June 30, 2017
23. BlackRock Institutional Trust Company, N.A. 5,862 N/A Dec. 31, 2016
24. MORGAN STANLEY 4,095 N/A March 31, 2017
25. MORGAN STANLEY 4,095 N/A March 31, 2017
26. UBS AG 3,500 N/A Sept. 30, 2014
27. BlackRock Inc. 2,620 N/A Sept. 30, 2016
28. LADENBURG THALMANN FINANCIAL SERVICES INC 2,415 N/A March 31, 2018
29. LADENBURG THALMANN FINANCIAL SERVICES INC 2,415 N/A June 30, 2018
30. MetLife Securities, Inc 2,400 N/A Dec. 31, 2016

Seelos Therapeutics (SEEL)

140
 


Feedback